Skip to main content
Terug
Watch Compare

Neuronetics, Inc.

Datakwaliteit: 100%
STIM
Nasdaq Manufacturing Measuring & Analyzing Instruments
€ 1,39
▼ € 0,12 (-7,95%)
Marktkapitalisatie: 96,30 M
Prijs
€ 1,39
Marktkapitalisatie
96,30 M
Dagbereik
€ 1,38 — € 1,52
52-Weeksbereik
€ 0,80 — € 4,85
Volume
1.314.320
Openen € 1,51
50D / 200D Gem.
€ 1,51
8,15% below
50D / 200D Gem.
€ 2,45
43,30% below

Quick Summary

Belangrijkste Punten

Revenue grew 28,15% annually over 5 years — strong growth
Debt/Equity of 2,40 — high leverage
Negative free cash flow of -20,37 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 71,02%

Groei

Revenue Growth (5Y)
28,15%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)99,17%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-143,10%
Onder sectorgemiddelde (-53,47%)
ROIC-22,24%
Net Margin-26,15%
Op. Margin-21,08%

Veiligheid

Debt / Equity
2,40
Boven sectorgemiddelde (0,31)
Current Ratio2,24
Interest Coverage-4,14

Waardering

PE (TTM)
-2,47
Onder sectorgemiddelde (-1,47)
P/B Ratio3,52
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -2,5 -1,5
P/B 3,5 1,6
ROE % -143,1 -53,5
Net Margin % -26,2 -41,5
Rev Growth 5Y % 28,2 1,8
D/E 2,4 0,3

ETFs Holding This Stock

PSIL logo PSIL AdvisorShares Psychedelics ETF
3,03% weight
GAMNX GAMNX
0,24% weight
GMNAX GMNAX
0,24% weight
GGMMX GGMMX
0,24% weight
GMNCX GMNCX
0,24% weight
BRSIX BRSIX
0,17% weight
GACIX GACIX
0,01% weight
IRSSX IRSSX
0,00% weight
WEIMX WEIMX
0,00% weight
WEMMX WEMMX
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 99,17% Revenue Growth (3Y) 44,59%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 28,15% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 149,16 M Net Income (TTM) -39,00 M
ROE -143,10% ROA -27,84%
Gross Margin 48,48% Operating Margin -21,08%
Net Margin -26,15% Free Cash Flow (TTM) -20,37 M
ROIC -22,24% FCF Growth (3Y) N/A
Safety
Debt / Equity 2,40 Current Ratio 2,24
Interest Coverage -4,14 Asset Turnover 1,07
Working Capital 35,95 M Tangible Book Value -13,82 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2,47 Forward P/E N/A
P/B Ratio 3,52 P/S Ratio 0,65
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -21,16%
Market Cap 96,30 M Enterprise Value 134,00 M
Per Share
EPS (Diluted TTM) -0,59 Revenue / Share 2,15
FCF / Share -0,29 OCF / Share -0,29
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 52,24%
SBC-Adj. FCF -26,46 M Growth Momentum 71,02

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 149,16 M 74,89 M 71,35 M 65,21 M 55,31 M
Net Income -39,00 M -43,71 M -30,19 M -37,16 M -31,19 M
EPS (Diluted) -0,59 -1,38 -1,05 -1,38 -1,22
Gross Profit 72,31 M 54,16 M 51,71 M 49,72 M 43,66 M
Operating Income -31,44 M -34,56 M -30,55 M -35,11 M -27,56 M
EBITDA — — — — —
R&D Expenses 6,58 M 12,77 M 9,52 M 9,34 M 7,92 M
SG&A Expenses — — — — —
D&A 3,47 M 2,07 M 2,01 M 1,65 M 1,06 M
Interest Expense 7,60 M 7,29 M 5,42 M 4,25 M 4,02 M
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 141,55 M 140,90 M 115,83 M 116,88 M 141,22 M
Total Liabilities 115,31 M 109,10 M 81,64 M 59,82 M 56,05 M
Shareholders' Equity 22,38 M 27,71 M 34,19 M 57,06 M 85,18 M
Total Debt 65,81 M 55,15 M 59,28 M 35,95 M 35,34 M
Cash & Equivalents 28,13 M 18,46 M 59,68 M 70,34 M 94,14 M
Current Assets 61,55 M 58,12 M 93,79 M 98,77 M 115,33 M
Current Liabilities 30,52 M 31,27 M 19,81 M 33,20 M 15,70 M